Oligon™ is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our proprietary SeekR™ platform is used to digitally engineer and rapidly produce self-delivering therapeutics which target specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of products in oncology, yet our multimodal RNA platform can be harnessed to transform outcomes for any complex multigenic disease.
| Website | http://www.oligon.com |
| Revenue | $3.6 million |
| Employees | 7 (4 on RocketReach) |
| Industry | Biotechnology Research, Electronics, Manufacturing |
| Keywords | Genetic Engineering, Rna Therapeutics, Precision Medicine, Biotechnology, Drug Resistance, Therapeutic Development, Emerging Therapies, Novel Therapeutics, Gene Silencing, Rna Technology, Biotech Research, Pharmaceutical Research, Drug Discovery, Clinical Trials, Biomedical Research, Life Sciences |
| Competitors | Thermo Fisher Scientific, Illumina, Agilent Technologies, MilliporeSigma, Eurofins, QIAGEN, Twist Bioscience, GenScript, Integrated DNA Technologies, LGC +39 more (view full list) |
| SIC | SIC Code 367 Companies, SIC Code 36 Companies, SIC Code 3674 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies, NAICS Code 3344 Companies, NAICS Code 33441 Companies |
Looking for a particular Oligon employee's phone or email?
Oligon Questions
The Oligon annual revenue was $3.6 million in 2026.
Spyro Mousses is the Co-Founder of Oligon.
4 people are employed at Oligon.
Oligon is based in Montreal, Quebec.
The NAICS codes for Oligon are [33, 334, 3344, 33441].
The SIC codes for Oligon are [367, 36, 3674].
Top Oligon Employees
-
Spyro Mousses
Co-Founder at Oligon
Scottsdale, AZ, US35+ -
David Azorsa
Chief Scientific Officer at Oligon
Scottsdale, AZ, US25+
Related Companies
